Improving technologies to reduce abortion-related morbidity and mortality

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 1 SUPPL., 2004, Pages

  Rogo, K ^a  

^a WORLD BANK   (United States)

Author keywords

Abortion; Developing country; Manual vacuum aspiration; Medical abortion; Pregnancy test

Indexed keywords

ANTIBIOTIC AGENT; GEMEPROST; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL;

ABORTION; BLEEDING; CONFERENCE PAPER; CONTRACEPTION; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; GESTATIONAL AGE; HUMAN; INFECTION; INFORMED CONSENT; INTERMETHOD COMPARISON; LABORATORY TEST; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL EDUCATION; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; SAFETY; SEPSIS; TECHNOLOGY; TROPHOBLASTIC DISEASE; ULTRASOUND; VACUUM ASPIRATION; WORLD HEALTH ORGANIZATION;

EID: 2442435854     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.02.010     Document Type: Conference Paper

References (39)

1. World Health Organization. Maternal mortality in 1995: estimates developed by WHO, UNICEF, UNFPA (WHO/RHR/01.9). 2001;WHO, Geneva
2. World Health Organization. Unsafe abortion: global and regional estimates of incidence of and mortality due to unsafe abortion with a listing of available country data (WHO/RHT/MSM/97.16). 1998;WHO, Geneva
3. Rogo K.O. Induced abortion in sub-Saharan Africa. East Afr Med J. 70:1993;386-395
4. Henshaw S.K., Singh S., Haas T. The incidence of abortion worldwide. Int Fam Plann Perspect. 25:(Suppl):1999;S30-S38
5. Berer M. Making abortion safe: a matter of good public health policy and practice. Bull World Health Organ. 78:2000;580-592
6. Bongaarts J., Porter R.G. Fertility, biology and behavior: an analysis of proximate determinants. 1983;Academic Press, New York
7. Alan Guttmacher Institute. Sharing responsibility: women, society and abortion worldwide. 1999;AGI, New York
8. Rahman A., Katzin L., Henshaw S.K. A global review of laws on induced abortion, 1985-1997. Int Fam Plann Perspect. 24:(2):1998;56-94
9. Cook R.J., Dickens B.M., Bliss L.E. International developments in abortion laws from 1988 to 1998. Am J Public Health. 89:1999;579-586
10. McKay H.E., Rogo K.O., Dixon D.B. FIGO society survey: acceptance and use of new ethical guidelines regarding induced abortion for non-medical reasons. Int J Gynecol Obstet. 75:2001;327-336
11. Shew M.L., Hellerstedt W.L., Sieving R.E., Smith A.E., Fee R.M. Prevalence of home pregnancy testing among adolescents. Am J Public Health. 90:2000;974-976
12. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Evidence-based guideline No.7. London: RCOG Press, 2000
13. World Health Organization. Complications of abortion: technical and managerial guidelines for prevention and treatment. 1995;WHO, Geneva
14. Hord CE, Baird TL, Billings DL. Advancing the role of midlevel providers in abortion and post-abortion care: a global review and key future actions. Issues in Abortion Care No. 6. Carrboro, NC: Ipas, 1999
15. World Health Organization. Safe abortion: technical and policy guidance for health systems. 2003;WHO, Geneva
16. Westfall J.M., Sophocles A., Burggraf H., Ellis S. Manual vacuum aspiration for first-trimester abortion. Arch Fam Med. 7:1998;559-562
17. Greenslade F.C., Benson J., Winkler J., Henderson V., Wolf M., Leonard A. Summary of clinical and programmatic experience with manual vacuum aspiration. IPAS Adv Abortion Care. 3:(2):1993;1-4
18. Rogo K.O., Orero S., Oguttu M. Preventing unsafe abortion in western Kenya: An innovative approach through private physicians. Reprod Health Matter. 6:1998;77-83
19. Girvin S., Ruminjo R. An evaluation of manual vacuum aspiration instruments. 2002;EngenderHealth, New York
20. World Health Organization. Medical methods of termination of pregnancy. WHO Technical Report Series 871. Geneva: WHO, 1997
21. Creinin M.D. Randomized comparison of efficacy, acceptability and cost of medical vs. surgical abortion. Contraception. 62:2000;117-124
22. Schaff E.A., Stadalius L.S., Eisinger S.H., Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract. 44:1997;353-360
23. Winikoff B., Sivin I., Coyaji K.J., Cabezas E., Xiao B., Gu S., et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba and India: a comparative trial of mifepristone-misoprostol vs. surgical abortion. Am J Obstet Gynecol. 176:1997;431-437
24. Ngoc N.N., Winikoff B., Clark S., Ellertson C., Am K.N., Hieu D.T., et al. Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam. Int Fam Plann Perspect. 25:1999;10-14 and 33
25. Ashok P.W., Penney G.C., Flett G.M.M., Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 13:1998;2962-2965
26. Wong K.S., Ngai C.S.W., Khan K.S., Tang L.C., Ho P.C. Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial. Contraception. 54:1996;23-25
27. Blanchard K., Winikoff B., Coyaji K., Ngoc N.T.N. Misoprostol alone: a new method of medical abortion? J Am Med Women Assoc. 55:2000;189-190
28. Consensus Statement. Expert Meeting on Misoprostol, sponsored by Reproductive Health Technologies Project and Gynuity Health Projects. July 28, 2003. Washington DC
29. PATH and EngenderHealth. Misoprostol for obstetric and gynecologic uses: a literature review. 2nd ed. Seattle: PATH (April 2001). URL: http://www.rho.org/miso-lit-review.pdf
30. Costa S.H., Vessy M.P. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet. 341:1993;1258-1261
31. Costa S.H. Commercial availability of misoprostol and induced abortion in Brazil. Int J Genecol Obstet. 63:(Suppi 1):1998;S131-S139
32. UNDP/UNFPA/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. Methotrexate for termination of early pregnancy: a toxicology review. Reproductive Health Matters 1997; 9: 162-6
33. Postabortion Care Consortium Community Task Force. Essential elements of postabortion care: An expanded and updated model. Postabortion Care Consortium, July 2002
34. Hussein J., Fortney J. Puerperal sepsis and maternal mortality: what role for new technologies? Int J Gynecol Obstet. 2004;S52-S61
35. Tsu V.D., Langer A., Aldrich T. Postpartum hemorrhage in low-income countries: is the public health community using the right tools? Int J Gynecol Obstet. 2004;S42-S51
36. Sawaya G.F., Grady D., Kerliwoske K., Grimes D.A. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on meta-analysis. Obstet Gynecol. 87:1996;884-890
37. Cobb L., Putney P., Rochat R., Solo J., Buono N., Dunlop J., et al. Global evaluation of USAID's postabortion care program. October 2001;POPTECH, Washington DC
38. Rogo K.O., Bohmer L., Ombaka C. Community level dynamics of unsafe abortion in western Kenya and opportunities for prevention: summary of findings and recommendations from pre-intervention research. 1999;Pacific Institute for Women's Health, Los Angeles, CA
39. Elul B., Hajri S., Ngoc N.N., Ellertson C., Slama C.B., Pearlman E., et al. Can women in less-developed countries use simplified medical abortion regimens? Lancet. 357:2001;1402-1405